NHS COVID-19 vaccination programme
GPTKB entity
Statements (61)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:vaccine
|
gptkbp:administered_by |
gptkb:National_Health_Service_(NHS)
|
gptkbp:adverse_effects_monitoring |
conducted by MHRA
|
gptkbp:booster_doses |
available for eligible populations
|
gptkbp:collaboration |
local health authorities
universities for research with WHO and other health organizations |
gptkbp:collection |
to monitor vaccine effectiveness
|
gptkbp:community_feedback |
influenced vaccination strategies
|
gptkbp:community_health |
to combat COVID-19
|
gptkbp:community_outreach |
to increase vaccination uptake
|
gptkbp:community_vaccination_sites |
established across the UK
|
gptkbp:eligibility |
age and health status
|
gptkbp:goal |
achieve herd immunity
|
https://www.w3.org/2000/01/rdf-schema#label |
NHS COVID-19 vaccination programme
|
gptkbp:impact_on_hospitalizations |
reduced significantly
|
gptkbp:impact_on_mortality_rates |
decreased after vaccination rollout
|
gptkbp:is_funded_by |
gptkb:British_government
|
gptkbp:is_vulnerable_to |
allocated by government
monitored continuously documented and analyzed across the UK regions addressed by NHS evaluated through studies managed by NHS logistics |
gptkbp:mobile_vaccination_units |
deployed in remote areas
|
gptkbp:online_booking_system |
available for appointments
|
gptkbp:part_of |
UK's COVID-19 response strategy
UK's public health policy |
gptkbp:partnership |
pharmacies and GP practices
|
gptkbp:public_awareness |
to inform about vaccination benefits
|
gptkbp:public_reaction |
collected to improve services
|
gptkbp:reports_to |
to the UK government
|
gptkbp:research |
conducted on vaccine efficacy
|
gptkbp:started_in |
December 2020
|
gptkbp:target_audience |
adults and vulnerable groups
|
gptkbp:training_for_healthcare_workers |
provided for vaccine administration
|
gptkbp:vaccine_administration_sites |
set up in various locations
|
gptkbp:vaccine_administration_statistics |
reported regularly
|
gptkbp:vaccine_equity |
ensured for all demographics
|
gptkbp:vaccine_hesitancy_addressed |
through community engagement
|
gptkbp:vaccine_information |
available on NHS website
|
gptkbp:vaccine_misinformation |
combated through public education
|
gptkbp:vaccine_outreach |
targeted at minority communities
|
gptkbp:vaccine_outreach_programs |
conducted in schools
|
gptkbp:vaccine_passport |
introduced for travel purposes
|
gptkbp:vaccine_registration |
required for receiving the vaccine
|
gptkbp:vaccine_rollout_phases |
expanded to elderly populations
expanded to younger adults included children in clinical trials initially prioritized healthcare workers |
gptkbp:vaccine_rollout_success |
monitored by health authorities
|
gptkbp:vaccine_storage_requirements |
cold chain management
|
gptkbp:vaccine_supply_issues |
managed by government agencies
|
gptkbp:vaccine_uptake |
monitored by NHS.
|
gptkbp:vaccines_used |
gptkb:Johnson_&_Johnson
gptkb:Astra_Zeneca gptkb:Pfizer-Bio_NTech gptkb:Moderna |
gptkbp:bfsParent |
gptkb:National_Health_System
|
gptkbp:bfsLayer |
5
|